This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: The Salk Institute. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Samuel Lawrence Pfaff: Innovator in RNA Technology
Introduction
Samuel Lawrence Pfaff is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of molecular biology, particularly in the area of RNA technology. His innovative work has the potential to impact therapeutic approaches for various genetic diseases and cancers.
Latest Patents
Pfaff holds a patent for "High-efficiency reconstitution of RNA molecules." This patent includes synthetic RNA molecules designed for the reconstitution of RNA molecules, along with compositions and methods for utilizing these molecules. The technology allows for the delivery of a protein coding sequence through two or more viral vectors, such as adeno-associated viruses (AAVs). This method results in the reconstitution of full-length proteins within cells, which can be crucial for delivering therapeutic proteins to treat genetic diseases or cancer.
Career Highlights
Pfaff is affiliated with the Salk Institute, a leading research institution known for its groundbreaking work in biological research. His role at the institute has allowed him to collaborate with other experts in the field and contribute to advancements in RNA technology.
Collaborations
One of Pfaff's notable collaborators is Lukas Christoph Bachmann. Their partnership exemplifies the collaborative spirit of scientific research, where shared expertise can lead to innovative solutions in biotechnology.
Conclusion
Samuel Lawrence Pfaff's contributions to RNA technology through his patent and work at the Salk Institute highlight his role as an influential inventor in the field. His innovations have the potential to pave the way for new therapeutic strategies in medicine.